Accepted Manuscript Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition- Monika Aparecida Coronado, Raphael Josef Eberle, Nicole Bleffert, Sophie Feuerstein, Danilo Silva Olivier, Fabio Rogerio de Moraes, Dieter Willbold, Raghuvir Krishnaswamy Arni PII: S0166-3542(18)30376-0 DOI: https://doi.org/10.1016/j.antiviral.2018.10.019 Reference: AVR 4398 To appear in: Antiviral Research Received Date: 13 June 2018 Revised Date: 25 September 2018 Accepted Date: 24 October 2018 Please cite this article as: Coronado, M.A., Eberle, R.J., Bleffert, N., Feuerstein, S., Olivier, D.S., de Moraes, F.R., Willbold, D., Arni, R.K., Zika virus NS2B/NS3 proteinase: A new target for an old drug - Suramin a lead compound for NS2B/NS3 proteinase inhibition-, Antiviral Research (2018), doi: https:// doi.org/10.1016/j.antiviral.2018.10.019. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.